Difference between revisions of "Allergic conjunctivitis"

From Citizendium
Jump to: navigation, search
(Clinical presentation)
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
 
{{subpages}}
 
{{subpages}}
In [[allergy and immunology]], '''allergic conjunctivitis''' is "conjunctivitis due to [[hypersensitivity]] to various allergens."<ref>{{MeSH}}</ref>  From the immunologic standpoint, it may fall into any of the [[Gell and Coombs classification of immune reactions]] types. Clinically, it tends to be one of five syndromes:<ref name=eMed-Intro>{{citation
+
{{TOC|right}}
 +
In [[allergy and immunology]], as well as [[opthalmology]], '''allergic conjunctivitis''' is "conjunctivitis due to [[hypersensitivity]] to various allergens."<ref>{{MeSH}}</ref>   
 +
==Etiology==
 +
From the immunologic standpoint, it may fall into any of the [[Gell and Coombs classification of immune reactions]] types.  
 +
 +
The recently cloned [[interleukin-33]] (IL-33) is activated in [[allergic conjunctivitis]], and sensitizes [[T-lymphocyte]]s to produce IL-4, IL-5 and IL-13 upon challenge with anti-CD3 and anti-CD28.<ref>{{citation
 +
| journal = International Immunology
 +
| year = 2010
 +
  | volume = 22 | issue = 6 | pages = 479-489| doi= 10.1093/intimm/dxq035
 +
| title = Contribution of IL-33 to induction and augmentation of experimental allergic conjunctivitis
 +
| author = Saori Matsuba-Kitamura ''et al''
 +
| url =http://intimm.oxfordjournals.org/cgi/content/full/22/6/479
 +
}}</ref>
 +
==Clinical presentation==
 +
Clinically, it tends to be one of four syndromes, one of which has two subtypes (SAC and PAC):<ref name=eMed-Intro>{{citation
 
  | journal = eMedicine
 
  | journal = eMedicine
 
  | title = Conjunctivitis, Allergic: Overview
 
  | title = Conjunctivitis, Allergic: Overview
Line 7: Line 21:
 
  | url = http://emedicine.medscape.com/article/1191467-overview}}</ref>
 
  | url = http://emedicine.medscape.com/article/1191467-overview}}</ref>
 
#'''Seasonal and perennial allergic conjunctivitis (SAC) and (PAC)''':  since the conjunctivae and the nasal surfaces are immunologically similar tissue, [[allergic rhinitis]] may coexist. The differences between the seasonal and perennial is simple timing:  does the condition only occur in an "allergy season", when, for example, levels of a specific pollen are known to be high?
 
#'''Seasonal and perennial allergic conjunctivitis (SAC) and (PAC)''':  since the conjunctivae and the nasal surfaces are immunologically similar tissue, [[allergic rhinitis]] may coexist. The differences between the seasonal and perennial is simple timing:  does the condition only occur in an "allergy season", when, for example, levels of a specific pollen are known to be high?
#'''Vernal keratoconjunctivitis (VKC)''': this condition is chronic, and in both eyes, and is associated with a personal or family history of [[atopy]]. Atopic [[comorbidity|comorbidities]] include [[asthma]], [[eczema]], or [[seasonal allergic rhinitis]]
+
#'''Vernal keratoconjunctivitis (VKC)''': this condition is chronic, and in both eyes, and is associated with a personal or family history of [[atopy]]. Atopic [[comorbidity|comorbidities]] include [[asthma]], [[eczema]], or [[ allergic rhinitis|seasonal allergic rhinitis]]
 
#'''Atopic keratoconjunctivitis''' is also bilateral and chronic, with both similarities to and differences from VKC. It is a Gell and Coombs Type I hypersensitivity disorder. "Atopic dermatitis is a common hereditary disorder that usually has its onset in childhood; symptoms may regress with advancing age. Approximately 3% of the population is afflicted with atopic dermatitis, and, of these, approximately 25% have ocular involvement."<ref>Hogan MJ. "Atopic keratoconjunctivitis". ''Am J Ophthalmol.'' 1953;36:937-947.</ref>
 
#'''Atopic keratoconjunctivitis''' is also bilateral and chronic, with both similarities to and differences from VKC. It is a Gell and Coombs Type I hypersensitivity disorder. "Atopic dermatitis is a common hereditary disorder that usually has its onset in childhood; symptoms may regress with advancing age. Approximately 3% of the population is afflicted with atopic dermatitis, and, of these, approximately 25% have ocular involvement."<ref>Hogan MJ. "Atopic keratoconjunctivitis". ''Am J Ophthalmol.'' 1953;36:937-947.</ref>
#'''Giant papillary conjunctivitis (GPC)''' is an immune-mediated inflammatory disorder of superior tarsal conjunctiva. "As the name implies, the primary finding is the presence of "giant" [[]papill]ae, which are typically greater than 0.3 mm in diameter. It is believed that GPC represents an immunologic reaction to a variety of foreign bodies, which may cause prolonged mechanical irritation to the superior tarsal conjunctiva. Although [[contact lens]]es (hard and soft) are the most common irritant, ocular prostheses, extruded scleral buckles, and exposed sutures following previous surgical intervention may precipitate GPC."<ref name=eMed-Intro/>
+
#'''Giant papillary conjunctivitis (GPC)''' is an immune-mediated inflammatory disorder of superior tarsal conjunctiva. "As the name implies, the primary finding is the presence of "giant" [[papill]]ae, which are typically greater than 0.3 mm in diameter. It is believed that GPC represents an immunologic reaction to a variety of foreign bodies, which may cause prolonged mechanical irritation to the superior tarsal conjunctiva. Although [[contact lens]]es (hard and soft) are the most common irritant, ocular prostheses, extruded scleral buckles, and exposed sutures following previous surgical intervention may precipitate GPC."<ref name=eMed-Intro/>
 +
 
 
==Treatment==
 
==Treatment==
 
Intranasal [[corticosteroid]]s when used to treat [[allergic rhinitis]] may also help allergic conjunctivitis.<ref name="pmid20434199">{{cite journal| author=Prenner BM, Lanier BQ, Bernstein DI, Shekar T, Teper A| title=Mometasone furoate nasal spray reduces the ocular symptoms of seasonal allergic rhinitis. | journal=J Allergy Clin Immunol | year= 2010 | volume= 125 | issue= 6 | pages= 1247-1253.e5 | pmid=20434199  
 
Intranasal [[corticosteroid]]s when used to treat [[allergic rhinitis]] may also help allergic conjunctivitis.<ref name="pmid20434199">{{cite journal| author=Prenner BM, Lanier BQ, Bernstein DI, Shekar T, Teper A| title=Mometasone furoate nasal spray reduces the ocular symptoms of seasonal allergic rhinitis. | journal=J Allergy Clin Immunol | year= 2010 | volume= 125 | issue= 6 | pages= 1247-1253.e5 | pmid=20434199  

Latest revision as of 16:20, 22 August 2010

This article is developing and not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

In allergy and immunology, as well as opthalmology, allergic conjunctivitis is "conjunctivitis due to hypersensitivity to various allergens."[1]

Etiology

From the immunologic standpoint, it may fall into any of the Gell and Coombs classification of immune reactions types.

The recently cloned interleukin-33 (IL-33) is activated in allergic conjunctivitis, and sensitizes T-lymphocytes to produce IL-4, IL-5 and IL-13 upon challenge with anti-CD3 and anti-CD28.[2]

Clinical presentation

Clinically, it tends to be one of four syndromes, one of which has two subtypes (SAC and PAC):[3]

  1. Seasonal and perennial allergic conjunctivitis (SAC) and (PAC): since the conjunctivae and the nasal surfaces are immunologically similar tissue, allergic rhinitis may coexist. The differences between the seasonal and perennial is simple timing: does the condition only occur in an "allergy season", when, for example, levels of a specific pollen are known to be high?
  2. Vernal keratoconjunctivitis (VKC): this condition is chronic, and in both eyes, and is associated with a personal or family history of atopy. Atopic comorbidities include asthma, eczema, or seasonal allergic rhinitis
  3. Atopic keratoconjunctivitis is also bilateral and chronic, with both similarities to and differences from VKC. It is a Gell and Coombs Type I hypersensitivity disorder. "Atopic dermatitis is a common hereditary disorder that usually has its onset in childhood; symptoms may regress with advancing age. Approximately 3% of the population is afflicted with atopic dermatitis, and, of these, approximately 25% have ocular involvement."[4]
  4. Giant papillary conjunctivitis (GPC) is an immune-mediated inflammatory disorder of superior tarsal conjunctiva. "As the name implies, the primary finding is the presence of "giant" papillae, which are typically greater than 0.3 mm in diameter. It is believed that GPC represents an immunologic reaction to a variety of foreign bodies, which may cause prolonged mechanical irritation to the superior tarsal conjunctiva. Although contact lenses (hard and soft) are the most common irritant, ocular prostheses, extruded scleral buckles, and exposed sutures following previous surgical intervention may precipitate GPC."[3]

Treatment

Intranasal corticosteroids when used to treat allergic rhinitis may also help allergic conjunctivitis.[5]

References

  1. Anonymous (2021), Allergic conjunctivitis (English). Medical Subject Headings. U.S. National Library of Medicine.
  2. Saori Matsuba-Kitamura et al (2010), "Contribution of IL-33 to induction and augmentation of experimental allergic conjunctivitis", International Immunology 22 (6): 479-489, DOI:10.1093/intimm/dxq035
  3. 3.0 3.1 Parag A Majmudar (4 August 2010), "Conjunctivitis, Allergic: Overview", eMedicine
  4. Hogan MJ. "Atopic keratoconjunctivitis". Am J Ophthalmol. 1953;36:937-947.
  5. Prenner BM, Lanier BQ, Bernstein DI, Shekar T, Teper A (2010). "Mometasone furoate nasal spray reduces the ocular symptoms of seasonal allergic rhinitis.". J Allergy Clin Immunol 125 (6): 1247-1253.e5. DOI:10.1016/j.jaci.2010.03.004. PMID 20434199. Research Blogging.